125.12
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $125.12, with a volume of 424.66K.
It is up +0.75% in the last 24 hours and down -7.81% over the past month.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
See More
Previous Close:
$124.19
Open:
$124.84
24h Volume:
424.66K
Relative Volume:
0.52
Market Cap:
$5.30B
Revenue:
$2.81B
Net Income/Loss:
$-294.68M
P/E Ratio:
-5.4854
EPS:
-22.8098
Net Cash Flow:
$232.59M
1W Performance:
+0.81%
1M Performance:
-7.81%
6M Performance:
+4.03%
1Y Performance:
+0.34%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TFX
Teleflex Incorporated
|
125.12 | 5.30B | 2.81B | -294.68M | 232.59M | -22.81 |
|
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-28-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-28-26 | Initiated | UBS | Neutral |
| Jul-09-26 | Initiated | BMO Capital Markets | Outperform |
| Jun-08-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-08-26 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-13-26 | Upgrade | BofA Securities | Underperform → Neutral |
| Mar-27-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-27-26 | Upgrade | Needham | Hold → Buy |
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
China Airway Management Market Forecast to 2033Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth Opportunities - GlobeNewswire Inc.
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Reasons to Add Globus Medical Stock to Your Portfolio Now - Zacks Investment Research
Charles River Gains 75.8% in a Year: What's Driving the Rally? - Zacks Investment Research
TFX or SONVY: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Is It Prudent to Add Teleflex Stock to Your Portfolio Now? - Zacks Investment Research
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research
Teleflex Incorporated (TFX) stock price, news, quote and history - Yahoo Finance Singapore
Teleflex stock falls 2.52 percent after quarterly results - ad-hoc-news.de
Teleflex Incorporated (TFX) Stock forecasts - Yahoo Finance Singapore
Teleflex Incorporated (TFX) Stock Forecasts - finance.yahoo.com
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now - Zacks Investment Research
Teleflex stock holds near USD 125 as target cuts sharpen the debate - AD HOC NEWS
Teleflex Incorporated (TFX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is This the Right Time to Add DGX Stock to Your Portfolio? - Zacks Investment Research
Corient Private Wealth LP Has $2.92 Million Holdings in Teleflex Incorporated $TFX - MarketBeat
Teleflex Incorporated (TFX) Stock Analysis: Potential 23% Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Bank of America Corp DE Invests $61.16 Million in Teleflex Incorporated $TFX - MarketBeat
Teleflex (TFX) Adds A Board Veteran, Is The 19% Undervalued View Enough? - Yahoo Finance
Teleflex Stock Price Forecast. Should You Buy TFX? - StockInvest.us
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo Finance
Teleflex Study Backs Radial Access for Iliac Stenting - MyChesCo
Teleflex Inc. stock dips after strong Q2 earnings and Hold consensus - ad-hoc-news.de
Teleflex stock heads into the open after a 2.7% drop - ad-hoc-news.de
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Director Sean Salmon receives Teleflex (NYSE: TFX) stock and options - Stock Titan
New Teleflex (NYSE: TFX) director Sean Salmon reports no stock stake - Stock Titan
Teleflex (NYSE: TFX) Welcomes Sean M. Salmon to Board, Bringing Expertise from $12.5B Medtronic Cardiovascular Portfolio - Kalkine Media
Teleflex stock heads into the open after a 3.3 percent weekly gain - ad-hoc-news.de
People on the Move: Sean M. Salmon Joins Teleflex Board of Directors - BioBuzz
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines - Yahoo Finance
Teleflex Expands Board, Appoints Sean M. Salmon as New Director - Kalkine Media
Teleflex appoints Sean M. Salmon to board - Medical Buyer
Teleflex elects Sean M. Salmon to board, appoints him to Growth and Operating Committee - TradingView
Teleflex stock holds after a Q2 earnings beat - ad-hoc-news.de
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines - TradingView
Teleflex Inc. stock holds steady after strong Q2 earnings beat and updated 2026 guidance - ad-hoc-news.de
Medtronic veteran joins Teleflex’s board - MassDevice
Teleflex Appoints Medtronic Veteran Sean Salmon to Board of Directors - citybiz
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Nigeria
Teleflex Incorporated Announces Appointment of Sean M. Salmon to Board of Directors and to the Growth and Operating Committee, Effective September 8, 2026 - marketscreener.com
Teleflex appoints former Medtronic executive to board - investing.com
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Canada
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com India
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com UK
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - Teleflex
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - Business Wire
Teleflex appoints former Medtronic executive to board By Investing.com - Investing.com Australia
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):